Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents

Atherosclerosis. 1986 May;60(2):101-10. doi: 10.1016/0021-9150(86)90002-x.

Abstract

Smooth muscle cells isolated from atherosclerotic lesions of human aorta retain in primary culture their intrinsic in vivo characteristics: namely, enhanced proliferative activity and high lipid levels. We have tested the effect of different compounds on [3H]thymidine uptake and on the levels of phospholipids, triglycerides, cholesterol, and cholesteryl esters in cultured aortic cells. Effects, such as the inhibition of cellular proliferation and/or lowering of the intracellular lipid levels which would be regarded as antiatherosclerotic if exerted in vivo, were observed in vitro by the following compounds: dibutyryl cyclic AMP, cholera toxin, forskolin, methylisobutylxanthine, stable prostacyclin analogues, prostaglandins E2 and D2, verapamil, reserpine, alpha-tocopherol, butylated hydroxytoluene, lipostabil, and high density lipoproteins. In this paper, we discuss the possibility of using a primary culture of smooth muscle cells from an atherosclerotic human aorta for testing drugs for possible antiatherosclerotic activity.

MeSH terms

  • Antioxidants / pharmacology
  • Aorta / cytology
  • Aorta / drug effects*
  • Aorta / metabolism
  • Arteriosclerosis / drug therapy*
  • Bucladesine / pharmacology
  • Calcium / antagonists & inhibitors
  • Cell Division / drug effects
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Drug Evaluation, Preclinical
  • Humans
  • Lipid Metabolism
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • Prostaglandins / pharmacology

Substances

  • Antioxidants
  • Prostaglandins
  • Bucladesine
  • Cyclic AMP
  • Calcium